Cargando…
Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
Metabolic reprogramming and epithelial-mesenchymal plasticity are both hallmarks of the adaptation of cancer cells for tumor growth and progression. For metabolic changes, cancer cells alter metabolism by utilizing glucose, lipids, and amino acids to meet the requirement of rapid proliferation and t...
Autores principales: | Sun, Nai-Yun, Yang, Muh-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252305/ https://www.ncbi.nlm.nih.gov/pubmed/32509584 http://dx.doi.org/10.3389/fonc.2020.00792 |
Ejemplares similares
-
Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
por: Nouri, Mannan, et al.
Publicado: (2014) -
Revisiting epithelial‐mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
por: Liao, Tsai‐Tsen, et al.
Publicado: (2017) -
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017) -
Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015) -
Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2022)